罗氏约18亿美元现金收购美国分子诊断公司GenMark Diagnostics

2021-03-15 jackzhao MedSci原创

据华尔街日报报道,罗氏(Roche)将以18亿美元收购美国分子病理检验生产商GenMark Diagnostics,根据收购协议,罗氏将以每股24.05美元全现金收购GenMark,较GenMark

据华尔街日报报道,罗氏(Roche)将以18亿美元收购美国分子病理检验生产商GenMark Diagnostics,根据收购协议,罗氏将以每股24.05美元全现金收购GenMark,较GenMark 2月10日的收市价溢价43%,预计将于第二季完成。

该交易已获得罗氏(Roche)和GenMark董事会的批准,预计将于今年第二季度完成。

Should You Buy GenMark Diagnostics, Inc (GNMK) Stock After it Is Down  12.16% in a Week? - InvestorsObserver

罗氏诊断公司首席执行官Thomas Schinecker表示:“收购GenMark Diagnostics将扩大我们的分子诊断产品组合,以包括可以为患者及其医疗保健提供者快速抗击传染病的解决方案,”交易价值18亿美元,比GenMark 2月10日的收盘价溢价约43%,GenMark在2月10日即可能的出售交易出现之前的最后一个交易日。

罗氏表示,收购完成后,GenMark's将继续在加利福尼亚的卡尔斯巴德(Carlsbad)开展主要业务。

GenMark Diagnostics 成立于2010年,总部位于加利福尼亚州卡尔斯巴德。它是一家自动化,多重分子诊断测试系统的提供商,该系统可检测和测量DNA和RNA靶标以诊断疾病并优化患者治疗。 GenMark的eSensor技术基于DNA杂交和电化学检测的原理。该公司的eSensor技术对目标生物标志物具有高度特异性,并非基于荧光或光学检测,因此诊断检测不易发生样品污染风险,不需要耗时的洗涤和制备步骤。该业务部门包括基于其专有的eSensor检测技术的仪器和分子测试的开发,制造,销售和支持。

它提供ePlex仪器和呼吸道病原体检测面板,该系统将自动化的核酸提取和扩增与其eSensor技术集成在一起,使使用ePlex系统的操作员可以将患者样品直接放入其测试盒中并获得结果。该公司还提供“血液培养物鉴定革兰氏阳性和阴性”面板,“血液培养物鉴定真菌病原体”面板和“ ePlex胃肠道病原体”面板。此外,它还提供XT-8仪器以及相关的诊断和研究测试,以及某些定制制造的试剂,以支持使用工作站和一次性测试盒进行的各种分子测试。此外,该公司还提供用于XT-8系统的诊断测试,包括呼吸道病毒检测,囊性纤维化基因分型测试,华法林敏感性测试,血栓形成风险测试,丙型肝炎病毒基因分型测试以及相关的定制试剂,以及2C19基因分型测试和eSensor SARS-CoV-2测试。其主要业务在美国。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-16 painkiller

    有钱还是好啊

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-15 ms6000000611611957

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-15 ms1000001618169783

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-15 神盾医疗局局长Jack

    big deal😀

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1685802, encodeId=284916858028e, content=<a href='/topic/show?id=24cc592346' target=_blank style='color:#2F92EE;'>#diagnostic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5923, encryptionId=24cc592346, topicName=diagnostic)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6fc28270220, createdName=124984edm31暂无昵称, createdTime=Wed Dec 29 13:05:14 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784186, encodeId=bb741e84186a2, content=<a href='/topic/show?id=77ac592506' target=_blank style='color:#2F92EE;'>#diagnostics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5925, encryptionId=77ac592506, topicName=diagnostics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffd5416, createdName=bettycmoon, createdTime=Sun May 02 06:05:14 CST 2021, time=2021-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1639730, encodeId=804c1639e30f4, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Wed Dec 08 14:05:14 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622917, encodeId=020a162291e79, content=<a href='/topic/show?id=517d3168e03' target=_blank style='color:#2F92EE;'>#分子诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31687, encryptionId=517d3168e03, topicName=分子诊断)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Wed Mar 17 09:05:14 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948647, encodeId=e74994864ef7, content=有钱还是好啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=13b32449037, createdName=painkiller, createdTime=Tue Mar 16 12:29:46 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948474, encodeId=c8409484e466, content=…, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48ba5469392, createdName=ms6000000611611957, createdTime=Mon Mar 15 21:53:43 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948451, encodeId=f10594845127, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24415469423, createdName=ms1000001618169783, createdTime=Mon Mar 15 19:56:59 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948439, encodeId=2d1194843953, content=big deal😀, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Mon Mar 15 18:20:52 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948434, encodeId=7d7c9484346c, content=好文章!, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:14:15 CST 2021, time=2021-03-15, status=1, ipAttribution=)]
    2021-03-15 jyzxjiangqin

    好文章!

    0

相关资讯

视力下降疗法Faricimab将两次治疗之间的时间延长了四个月

罗氏(Roche)的研究性双特异性抗体Faricimab已被发现可将糖尿病性黄斑水肿(DME)和新生血管性老年黄斑变性(nAMD)患者的治疗间隔延长多达四个月。